Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Dirven

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Epilepsia|November 16, 2022
First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsyPim B van der Meer, Marta Maschio, Linda Dirven, et al.
Neuro-Oncology|March 28, 2015
Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic reviewJohan A F Koekkoek, Melissa Kerkhof, Linda Dirven, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 15, 2017
Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patientsLinda Dirven, Mogens Groenvold, Martin J B Taphoorn, et al.
Current Neurology and Neuroscience Reports|May 14, 2013
Health-related quality of life in patients with brain tumors: limitations and additional outcome measuresLinda Dirven, Jacob C Reijneveld, Neil K Aaronson, et al.
International Journal of Cancer|October 5, 2019
The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic reviewMark P van Opijnen, Linda Dirven, Ida E M Coremans, et al.
Journal of Neuro-Oncology|March 20, 2019
Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumorsQuirien Oort, Martin J B Taphoorn, Sietske A M Sikkes, et al.
Neuro-Oncology Practice|September 30, 2021
Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic reviewMarjolein E de Bruin, Pim B van der Meer, Linda Dirven, et al.
Cancers|August 9, 2020
The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective StudyMarthe C M Peeters, Hanneke Zwinkels, Johan A F Koekkoek, et al.
Psycho-Oncology|January 27, 2022
Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?Quirien Oort, Hanneke Zwinkels, Johan A F Koekkoek, et al.
Journal of Neuro-Oncology|April 6, 2021
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaintsPim B van der Meer, Johan A F Koekkoek, Martin J van den Bent, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Epilepsia|November 16, 2022
First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsyPim B van der Meer, Marta Maschio, Linda Dirven, et al.
Neuro-Oncology|March 28, 2015
Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic reviewJohan A F Koekkoek, Melissa Kerkhof, Linda Dirven, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 15, 2017
Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patientsLinda Dirven, Mogens Groenvold, Martin J B Taphoorn, et al.
Current Neurology and Neuroscience Reports|May 14, 2013
Health-related quality of life in patients with brain tumors: limitations and additional outcome measuresLinda Dirven, Jacob C Reijneveld, Neil K Aaronson, et al.
International Journal of Cancer|October 5, 2019
The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic reviewMark P van Opijnen, Linda Dirven, Ida E M Coremans, et al.
Journal of Neuro-Oncology|March 20, 2019
Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumorsQuirien Oort, Martin J B Taphoorn, Sietske A M Sikkes, et al.
Neuro-Oncology Practice|September 30, 2021
Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic reviewMarjolein E de Bruin, Pim B van der Meer, Linda Dirven, et al.
Cancers|August 9, 2020
The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective StudyMarthe C M Peeters, Hanneke Zwinkels, Johan A F Koekkoek, et al.
Psycho-Oncology|January 27, 2022
Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?Quirien Oort, Hanneke Zwinkels, Johan A F Koekkoek, et al.
Journal of Neuro-Oncology|April 6, 2021
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaintsPim B van der Meer, Johan A F Koekkoek, Martin J van den Bent, et al.
Pageof 15